Related Experiment Videos
[Clinical significance of a multiple myeloma cell line, derived from a case associated with hyperammonemia]
Abstract:
Recently, there have been several reports describing patients with multiple myeloma complicated by consciousness disturbance due to hyperammonemia. Here we report a patient with multiple myeloma and hyperammonemia, who died after rapid progression of the disease. A 71-year-old man who had been diagnosed as having Bence Jones protein (kappa)-type multiple myeloma in 1996 was readmitted to our hospital in February 1997 because of worsening bone pain, renal dysfunction, and hypercalcemia. Bone marrow aspiration yielded an almost dry tap, and the bone marrow was found to be completely occupied by immature plasma cells. Although liver dysfunction was slight, the serum ammonia level was high and increased gradually. Despite treatment, the patient died due to cerebral embolism and progression of plasmacytic leukemia in October 1997. Peripheral blood sampled at the time of death showed a serum ammonia level of 204 micrograms/dl, and the myeloma calls were cultured using monolayered bone marrow stromal cells as feeder cells. This led to the successful establishment of a cell line. The level of ammonia in the supernatant was high, indicating that the cultured myeloma cells produced and released ammonia.
Insights
Multiple myeloma can cause hyperammonemia, leading to consciousness disturbance. This case study highlights how myeloma cells may produce ammonia, contributing to disease progression and patient death.
Area of Science:
- Hematology
- Oncology
- Nephrology
Background:
- Multiple myeloma is a plasma cell malignancy.
- Hyperammonemia can cause neurological complications.
Observation:
- A 71-year-old man with kappa-type multiple myeloma presented with bone pain, renal dysfunction, and hypercalcemia.
- Despite treatment, the patient experienced rapid disease progression, cerebral embolism, and plasmacytic leukemia.
- High serum ammonia levels were observed and increased progressively.
Findings:
- Bone marrow examination revealed extensive infiltration by immature plasma cells.
- Cultured myeloma cells demonstrated ammonia production and release.
- Established a new myeloma cell line from patient's peripheral blood.
Implications:
- Myeloma cells may be a source of hyperammonemia in affected patients.
- Understanding ammonia production by myeloma cells could inform new therapeutic strategies.
- This case underscores the complex pathophysiology of multiple myeloma complications.